Skip to main content
48°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages InMode Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INMD
March 29, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
INMD
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages InMode Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INMD
March 29, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
INMD
Second Chance For Nikola? Electric Trucks Return To Customers After Fire Recalls With New Features
March 29, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
NKLA
BioMedNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at Upcoming MedInvest Conference
March 28, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
PCSA
TinyGemsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at Upcoming MedInvest Conference
March 28, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
PCSA
FDA Approves For Akebia Therapeutics' Vafseo For Kidney Disease Associated Anemia
March 28, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
AKBA
Medicus Pharma says U.S. FDA has provided comments on Phase 2 Clinical Protocol of SKNJCT-003
March 28, 2024
Via
News Direct
Exposures
Product Safety
Medicus Pharma says U.S. FDA has provided comments on Phase 2 Clinical Protocol of SKNJCT-003
March 28, 2024
Via
TheNewswire.com
Exposures
Product Safety
Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
March 28, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
ABBV
ALEC
ALNY
BIIB
Reddit Inc. (NYSE: RDDT) Surges, Uncovering Undervalued Opportunities: DYAI, INBS, MESO, VTAK
March 28, 2024
Via
AB Newswire
Topics
Initial Public Offering
Exposures
Product Safety
Securities Market
Tickers
ASX:MSB
DYAI
INBS
MESO
Merck Stock Soars On FDA Approval for Winrevair: Technical Analysis And Market Outlook
March 27, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
MRK
Medtronic's Latest Generation Of Transcatheter Aortic Valve Replacement Implant Passes FDA's Muster, Shares Gain
March 27, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
MDT
InvestorNewsBreaks – Beyond Air Inc. (NASDAQ: XAIR) Reports on $16M Registered Direct Offering with Health-Care Focused Investors
March 27, 2024
Via
Investor Brand Network
Exposures
COVID-19
Product Safety
Tickers
XAIR
Supreme Court Signals Unlikelihood of Restricting Abortion Pill Access, Questions Legal Standing
March 27, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
CVS
WBA
Ondine Biomedical achieves milestone with NHS trust's adoption of Steriwave
March 27, 2024
Via
News Direct
Exposures
Product Safety
Ondine Biomedical achieves milestone with NHS trust's adoption of Steriwave
March 27, 2024
Via
TheNewswire.com
Exposures
Product Safety
Merck's $11B Bet Pays As FDA Approves Sotatercept For Rare Lung Disease
March 27, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
BMY
MRK
Merck's Cardiovascular 'Renaissance' Is Here With The First Approval Of A $10 Billion Franchise
March 26, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
MRK
Upcoming Stock Dividend Coupled with Approved Share Structure Reduction Intended to Counter Short Selling and Boost Institutional Investment, Key Company Presentation Coming Up in UK: NRXP
March 26, 2024
Via
Get News
Exposures
Product Safety
After Almost 4 Years, FDA Says Mesoblast Phase 3 Therapy Data Can Support Resubmission For Serious Complications in Children Following Stem Cell Transplant
March 26, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ASX:MSB
MESO
Elon Musk-Backed Brain Chip Implant Neuralink Under Scrutiny Lens Following FDA's Oversight Regulatory Compliance
March 26, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
AIEQ
BKES
QRFT
ROBO
Tung Sin Biomedical EYESBRIGHT Obtains U.S. Food and Drug Administration (FDA) Import Approval, Set to Launch on Amazon to Seize North American Opportunities
March 26, 2024
Via
MerxWire
Exposures
Product Safety
Tickers
AMZN
PRISM MarketView Previews Anticipated FDA Drug Approvals for 2024
March 25, 2024
Via
AB Newswire
Exposures
COVID-19
Product Safety
Nova Biomedical New Generation StatStrip Glucose Hospital Meter Obtains FDA 510k Clearance
March 25, 2024
Via
PRLog
Exposures
Product Safety
Abortion Back In Supreme Court Showdown In Election Year, Opponents Challenge Mifepristone Safety
March 25, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
CVS
WBA
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Participation at American Association for Cancer Research Annual Meeting
March 25, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
PCSA
FDA Delays Decision For Regeneron's Inaugural Blood Cancer Therapy, Highlights Trial Concerns
March 25, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
REGN
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Closes on $6.5M Registered Direct Offering
March 25, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
GNPX
TechMediaBreaks – Genprex Inc. (NASDAQ: GNPX) Closes on $6.5M Registered Direct Offering
March 25, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
GNPX
FDA Gives Emergency Use Nod To Invivyd's Antibody To Prevent COVID-19 Infection In Adults, Adolescents With Weak Immune System
March 25, 2024
Via
Benzinga
Exposures
COVID-19
Product Safety
Tickers
IVVD
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.